Proto Labs, Inc. Earnings Recaps
Q2 2026
Aug 4, 2026
Proto Labs’ shares were little changed, declining 0.1% as the market digested solid but not breakout results, reflecting steady execution without meaningful new catalysts or concerns in the quarter.
Key takeaways
- Revenue rose on continued double-digit growth, driven by 13% growth in Injection Molding and 20% growth in CNC Machining in the factory segment.
- Revenue per customer increased 17% year-over-year, signaling deeper engagement with larger, strategic accounts.
- European business revenue grew 9% YoY, aligning with early progress from recent go-to-market restructuring, but profitability remains a work in progress.
- Gross margins expanded with operating cost leverage, supported by investments in quality and operational efficiency.
- Management emphasized ongoing transformation initiatives and a strategic focus on broadening customer relationships, with leadership changes to strengthen commercial and quality functions.
Q1 2026
May 5, 2026
Shares fell 0.7% after the quarter as investors digested solid top-line growth alongside ongoing operational investments and a cautious tone on 2026 transformation efforts. Despite double-digit revenue growth and margin expansion, the market appears hesitant amid early-stage strategic resets and increased focus on operational scaling.
Key takeaways
- First quarter revenue rose 10% year-over-year, driven by strength in CNC machining (+20% growth) and U.S. market (+12%).
- Revenue per customer increased 20%, supported by deeper engagement with larger aerospace, defense, and medical clients.
- Non-GAAP earnings per share reached a five-year high, driven by margin expansion and operating leverage.
- Operational investments include quality improvements in injection molding and the launch of a Global Capability Center in India to support scaling.
- A strategic reset in Europe and ongoing organizational changes signal 2026 will be a year focused on transformation rather than acceleration of growth.